Pilbara Exploration Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Morgan Stanley Reiterates Equalweight Rating on Novo Nordisk (NOVOB:DC) (NVO)
June 23, 2025 1:35 PM EDTMorgan Stanley analyst Thibault Boutherin reiterated an Equalweight rating and DKK550.00 price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO).
The analyst comments "H&H partnership termination (see press release here): Novo entered the arrangement with H&H before the 22 May (date of removal of sema from FDA shortage list) in order to facilitate the transition of patients on compounded semaglutide to Wegovy. Management reiterated that mass compounding and mass personalisation are against Novo's values and the direction they see for the market in the long term, and stated that Novo will not... More
